ONXEO (EPA:ALONX) | WebDisclosure

Basculer en Français

11182	Companies
247309	Keywords
175149	Articles
133610	Press releases

Home
Companies
ONXEO

PRESS RELEASE

published on 10/30/2025 at 09:04, 11 months 16 days ago

Rapport financier semestriel 2025
BRIEF

published on 10/30/2025 at 09:03, 11 months 16 days ago

Bilan financier et stratégique de Valerio Therapeutics pour le 1er semestre 2025

Recentrage Stratégique Valerio Therapeutics Résultats Financiers 2025 Plateformes V-Body Recherche Partenariats
BRIEF

published on 10/30/2025 at 09:03, 11 months 16 days ago

Valerio Therapeutics' financial and strategic review for the first half of 2025

Strategic Refocusing Valerio Therapeutics 2025 Financial Results V-Body Platforms Seeking Partnerships
PRESS RELEASE

published on 10/30/2025 at 09:00, 11 months 16 days ago

Press Release Publication Half-Year Financial Report 2025
Valerio Therapeutics S.A. announces first-half 2025 financial results, discontinuation of clinical activities, and strategic refocus on preclinical R&D. Strengthened financial structure through shareholder advances and capital increases

Financial Results Valerio Therapeutics First-half 2025 Preclinical R&D Shareholder Advances
PRESS RELEASE

published on 10/30/2025 at 08:58, 11 months 16 days ago

Communiqué de presse Mise à disposition du rapport semestriel 2025
Valerio Therapeutics annonce ses résultats financiers du 1er semestre 2025 et fait le point sur ses activités. Renforcement de la R&D préclinique avec les plateformes V-Body et chimie intégrée

Résultats Financiers Valerio Therapeutics R&D Préclinique V-Body Chimie Intégrée
BRIEF

published on 03/19/2025 at 15:32, 1 year 6 months ago

Valerio Therapeutics Announces Board Members and Their Roles

Board Members Valerio Therapeutics Corporate Roles Paris-based Company Executive Responsibilities
BRIEF

published on 03/19/2025 at 15:32, 1 year 6 months ago

Valerio Therapeutics annonce la composition de son conseil d'administration et leurs fonctions

Membres Du Conseil D'administration Valerio Therapeutics Rôles En Entreprise Entreprise Basée À Paris Responsabilités Exécutives
PRESS RELEASE

published on 03/19/2025 at 15:27, 1 year 6 months ago

Inside Information / Other news releases
Valerio Therapeutics announces new board members and their positions in other companies as of March 19, 2025

Board Members Positions Valerio Therapeutics Other Companies March 19 2025
BRIEF

published on 03/19/2025 at 12:35, 1 year 6 months ago

Décisions du conseil d'administration de Valerio Therapeutics

Assemblée Des Actionnaires Fractionnement Des Actions Changements De Directeur Résolutions Du Conseil D'administration Modifications D'articles
BRIEF

published on 03/19/2025 at 12:35, 1 year 6 months ago

Valerio Therapeutics Board Meeting Decisions

Director Changes Shareholder Meeting Share Split Board Resolutions Article Amendments

Accesswire

Published on 10/15/2026 at 19:25, 13 minutes ago

Datavault AI Highlights Data Futures Platform Patent Amid Tokenized Stock Exemption
Published on 10/15/2026 at 16:10, 3 hours 28 minutes ago

North Shore Announces Extension to Falcon Property Option Agreement and Resource Stock Digest Engagement
Published on 10/15/2026 at 15:15, 4 hours 23 minutes ago

Gold Terra to Host Community Town Hall Meeting in Yellowknife on October 21, 2026
Published on 10/15/2026 at 14:31, 5 hours 7 minutes ago

First Breach to Present at the 20th Annual LD Micro Main Event
Published on 10/15/2026 at 14:05, 5 hours 33 minutes ago

Innodata to Report Third Quarter 2026 Results

View all ACCESSWIRE

EQS Group

Published on 10/15/2026 at 18:30, 1 hour 8 minutes ago

Avolta's Q3 2026 trading update invitation
Published on 10/15/2026 at 18:03, 1 hour 35 minutes ago

AIXTRON Q3 2026: Order intake and operating profitability significantly exceed market expectations
Published on 10/15/2026 at 18:00, 1 hour 38 minutes ago

BOA Concept Group étoffe son offre et intègre les AMR KUKA
Published on 10/15/2026 at 18:00, 1 hour 38 minutes ago

ROCTOOL: INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 10/15/2026 at 18:00, 1 hour 38 minutes ago

Supervisory Board appoints Dr. Marc-Alexander Mahl to the Fresenius Management Board and extends Sara Hennicken’s contract

Les Echos

Published on 10/15/2026 at 18:50, 48 minutes ago

September & first 9 months of 2026 traffic figures - Revision of Traffic assumptions for 2026
Published on 10/15/2026 at 18:50, 48 minutes ago

Trafic du mois de septembre et des 9 premiers mois de l'année 2026 - Révision des hypothèses de trafic pour l'année 2026
Published on 10/15/2026 at 18:16, 1 hour 22 minutes ago

Déclaration des droits de vote au 30 septembre 2026
Published on 10/15/2026 at 18:14, 1 hour 24 minutes ago

Déclaration des droits de vote au 31 août 2026
Published on 10/15/2026 at 18:00, 1 hour 38 minutes ago

i2S : Chiffre d'Affaires T3 2026

View all LES ECHOS COMFI WIRE